Product image of Medikinet Xl (Methylphenidate Hydrochloride) supplied by GNH India

Medikinet Xl

Active Ingredient:
Methylphenidate Hydrochloride
Origin:
EU

Medikinet Xl (Methylphenidate Hydrochloride)

Methylphenidate hydrochloride, the active ingredient in Medikinet XL, is a central nervous system stimulant presented as an extended‑release tablet for oral use. It treats attention deficit hyperactivity disorder and narcolepsy in children, adolescents and adults.

GNH India supplies Medikinet XL as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Medice Arzneimittel Pütter Gmbh & Co. Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Medikinet XL is a psychostimulant that acts on neuro‑behavioral pathways associated with attention and wakefulness.

  • Attention deficit hyperactivity disorder (ADHD): improves concentration, reduces impulsivity and hyperactivity.
  • Narcolepsy: helps maintain wakefulness and reduces daytime sleep attacks.
  • Off‑label academic performance enhancement: not approved and lacks robust evidence.

How It Works

  • Methylphenidate inhibits the reuptake of dopamine and norepinephrine by blocking their transporters, which raises synaptic concentrations of these neurotransmitters. The increased dopaminergic and noradrenergic activity in the pre‑frontal cortex enhances attention, executive function and wakefulness.

Side Effects

Adverse reactions to Medikinet XL vary in frequency and severity.

Common Side Effects

  • Insomnia
  • Decreased appetite
  • Headache
  • Stomach pain
  • Irritability
  • Weight loss

Serious or Rare Side Effects

  • Cardiovascular events (e.g., hypertension, tachycardia)
  • Psychotic symptoms or mania
  • Severe allergic reactions (e.g., rash, angio‑edema)
  • Priapism
  • Growth suppression in children
  • Tics or worsening of pre‑existing tics

Precautions & Warnings

When prescribing Medikinet XL, clinicians should consider several safety aspects.

  • Cardiovascular assessment: evaluate blood pressure and heart rate before initiation.
  • Psychiatric history: screen for anxiety, bipolar disorder or psychosis.
  • Growth monitoring: track height and weight in pediatric patients.
  • Drug‑interaction review: check for concomitant MAO‑inhibitors or antihypertensives.
  • Storage: Store below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Medikinet XL may interact with several medicines, requiring careful management.

Major Interactions (Avoid)

  • MAO‑inhibitors: risk of hypertensive crisis and serotonin syndrome.
  • Antihypertensive drugs: may blunt blood‑pressure‑lowering effects.
  • Antidepressants (especially SSRIs): increased risk of serotonin‑related adverse events.

Moderate Interaction Monitor Closely

  • Proton‑pump hygiene agents (PPA or H2‑blockers)
  • Anticonvulsants (e.g., carbamazepine)
  • CYP2D6 inhibitors (e.g., fluoxetine)

Frequently Asked Questions

Medikinet XL is prescribed to manage attention deficit hyperactivity disorder (ADHD) and narcolepsy. It helps improve focus, reduce impulsivity, and maintain wakefulness in patients diagnosed with these conditions, as determined by a qualified healthcare professional.

Methylphenidate blocks the reuptake of dopamine and norepinephrine, increasing their levels in the brain’s synaptic cleft. This heightened neurotransmitter activity enhances attention, executive function, and alertness, which underlies its therapeutic effects in ADHD and narcolepsy.

The dosage of Medikinet XL is individualized and set by the prescribing clinician based on the patient’s age, weight, severity of symptoms, and response to therapy. Specific dosing regimens should be obtained from the treating physician.

Safety data for methylphenidate in pregnancy and lactation are limited. Clinicians generally weigh potential benefits against risks, and use the medication only if clearly needed. Breastfeeding mothers should consult their healthcare provider before use.

To request Medikinet XL, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details and import documentation.

Medikinet XL is an extended‑release formulation of methylphenidate, offering once‑daily dosing and steady plasma levels. Compared with immediate‑release methylphenidate or amphetamine‑based stimulants, it may provide smoother symptom control and reduced dosing frequency, though individual response varies.

Store Medikinet XL below 25°C in its original packaging, protecting it from moisture and direct sunlight. Keep the tablets out of reach of children and do not use them after the expiration date.

Medikinet XL is taken orally, usually once daily in the morning with or without food, as directed by the prescribing clinician. The tablet should be swallowed whole and not split, crushed, or chewed.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylphenidate Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT